Manfred, the number of shares I used (4,273,467) came from the news from the company: Maybe a mistake from the news and it is 14 millions shares
CHROMATICS COLOR SCIENCES INTERNATIONAL, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENT OF OPERATIONS
(UNAUDITED)
THREE MONTHS ENDED MARCH 31,
1998 1997
Revenues:
Lease, license and
service contracts $-- $1,500
Interest income 120,900 56,900
Other -- 300
120,900 58,700
COSTS AND EXPENSES:
Food and Drug Administration
("FDA") regulatory expenses 521,200 344,200
Patent application costs 124,300 123,100
Research and development costs253,300 55,100
General and administrative:
Compensation -
officers and employees 204,100 192,800
Consultants (including
$136,490 in compensation
costs relating to options
granted to consultants) 200,500 45,500
Legal fees 108,200 53,000
Accounting fees 25,300 13,600
Rent and storage 48,500 52,900
Insurance 50,100 52,500
Travel and entertainment 32,000 4,000
Repairs and maintenance 20,700 28,500
Depreciation and amortization 25,900 25,200
Payroll taxes 20,500 31,200
Stock administrative fees 32,900 9,100
Employee benefit plan 93,200 --
Promotional expenses 65,100 10,500
Other 65,900 60,900
1,891,700 1,102,100
NET LOSS $(1,770,800) $(1,043,400)
WEIGHTED AVERAGE NUMBER
OF COMMON SHARES AND
EQUIVALENTS OUTSTANDING 4,273,467 10,880,936
BASIC AND DILUTED LOSS
PER SHARE $(0.12) $(0.10)
SOURCE Chromatics Color Sciences International, Inc.
/CONTACT: Darby Macfarlane, Chief Executive Officer of Chromatics,
212-717-6544; or Richard Wool of Hill and Knowlton, 212-885-0523, for
Chromatics/
(CCSI)
Headlines Next Story
|
